UBQLN2 and amyotrophic lateral sclerosis: Importantly, ALS-associated mutations in UBQLN2 increase oligomerization, and the ubiquitin-binding generally disrupts LLPS, droplets, and aggregates (Dao et al., 2019; Zheng et al., 2021).